Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Use this ARTV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ARTV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ARTV SEC filings page. Lician reads the product cache first so this HTML stays unique to Artiva Biotherapeutics, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full ARTV income, balance, and cash tables.